Altai State Medical University is a public university in Barnaul, Russia. The university was known as Altai State Medical Institute until 1994. Altai State Medical University is located in the West Siberian part of the country. It is functioned by more than 60 departments and has seven faculties.

During the past decade, SBEI HPE Altai State Medical University of MoH and SD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SBEI HPE Altai State Medical University of MoH and SD" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Grifols Therapeutics LLC" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "EMD Serono" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SBEI HPE Altai State Medical University of MoH and SD" #1 collaborator was "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SBEI HPE Altai State Medical University of MoH and SD" are "Arthritis, Psoriatic" (2 trials), "Crohn Disease" (2 trials), "Von Willebrand Disease" (2 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency" (1 trials). Many other conditions were trialed in "SBEI HPE Altai State Medical University of MoH and SD" in a lesser frequency.

Most popular intervention types in "SBEI HPE Altai State Medical University of MoH and SD" are "Drug" (6 trials), "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Etrolizumab" (3 trials), "Alpha-1 MP" (2 trials), "Antihemophilic Factor (Recombinant)" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "SBEI HPE Altai State Medical University of MoH and SD" are 10 trials for "All" genders.

Currently, there are NaN active trials in "SBEI HPE Altai State Medical University of MoH and SD". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in SBEI HPE Altai State Medical University of MoH and SD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SBEI HPE Altai State Medical University of MoH and SD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

SBEI HPE Altai State Medical University of MoH and SD has several departments that took part in Clinical trials: "Altay Regional Oncology Center" - 5 trials